Greater remission rates in patients with early versus long-standing disease in biologic-naive rheumatoid arthritis patients treated with abatacept: A post hoc analysis of randomized clinical trial data - Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)150-151
Number of pages2
JournalInternational Journal of Advances in Rheumatology
Volume9
Issue number4
StatePublished - Dec 1 2011

ASJC Scopus subject areas

  • Rheumatology

Cite this